Why Trazodone Has Become the Most Prescribed Sleep Aid in America
Trazodone is an antidepressant that has become the most commonly prescribed medication for insomnia in the United States, despite never being FDA-approved for this indication. According to data from the National Ambulatory Medical Care Survey, trazodone accounts for more insomnia prescriptions than all FDA-approved sleep medications combined, including zolpidem (Ambien), eszopiclone (Lunesta), and suvorexant (Belsomra).
The off-label use emerged because at low doses (25 to 100 mg), trazodone produces significant sedation through its antagonism of serotonin 5-HT2A receptors and histamine H1 receptors without the dependency risk, cognitive impairment, and complex sleep behaviors associated with benzodiazepines and Z-drugs. Its antidepressant effects require much higher doses (150 to 600 mg), creating a convenient dose-dependent separation between its sleep-promoting and mood-altering properties.
How Trazodone Promotes Sleep
Trazodone’s sedative mechanism involves multiple receptor interactions at low doses. The primary sleep-promoting effect comes from potent antagonism of the 5-HT2A serotonin receptor, which at standard antidepressant doses would contribute to its mood-elevating effects but at low doses predominantly causes drowsiness. Additionally, trazodone blocks histamine H1 receptors (similar to diphenhydramine) and alpha-1 adrenergic receptors, both of which contribute to sedation.
Unlike benzodiazepines, which enhance GABA activity and suppress deep sleep architecture, trazodone has been shown to increase slow-wave sleep (deep sleep) in multiple polysomnography studies published in Sleep Medicine Reviews. This is particularly beneficial because slow-wave sleep is when the body performs the majority of physical repair, memory consolidation, and growth hormone release.
A study in the Journal of Clinical Psychopharmacology found that trazodone 50 mg reduced sleep onset latency (time to fall asleep) by approximately 10 to 15 minutes and increased total sleep time by 30 to 50 minutes compared to placebo in patients with primary insomnia.
Dosage for Sleep: Finding the Right Amount
The typical starting dose for insomnia is 25 to 50 mg taken 30 to 60 minutes before bedtime. Most people find effective relief in the 50 to 100 mg range. Doses above 100 mg for sleep purposes increase side effects without proportionally improving sleep quality and begin to engage antidepressant mechanisms.
Trazodone should be taken with a small snack. Food increases absorption and reduces the risk of orthostatic hypotension (dizziness upon standing), which is the most common side effect at any dose. A glass of milk and a few crackers, or a small piece of fruit, is sufficient.
Onset of sedation typically occurs within 30 to 60 minutes. The half-life is 5 to 9 hours, which means most of the drug is cleared by morning for the majority of users. However, individual metabolism varies, and some people experience next-day grogginess, particularly when first starting or at doses above 75 mg.
Physicians typically recommend starting at 25 mg and increasing by 25 mg increments every 3 to 5 nights until adequate sleep is achieved without next-day impairment. This cautious titration minimizes side effects and identifies the minimum effective dose.
Side Effects at Sleep Doses
The most frequently reported side effects at sleep-promoting doses include morning drowsiness (reported by 15 to 25% of users, usually resolves within the first week), dry mouth, dizziness or lightheadedness when standing up quickly, headache (mild, typically transient), and nasal congestion.
A rare but serious side effect is priapism (prolonged, painful erection) in men, occurring in approximately 1 in 6,000 to 1 in 10,000 male users. This is a medical emergency requiring immediate treatment. Men starting trazodone should be informed of this risk and instructed to seek emergency care if an erection lasts longer than 4 hours.
Orthostatic hypotension is dose-dependent and more common in older adults. Standing up slowly from lying or sitting positions reduces this risk. Adequate hydration also helps maintain blood pressure stability.
Dependency and Withdrawal: How Trazodone Compares
Unlike benzodiazepines (temazepam, lorazepam) and Z-drugs (zolpidem, eszopiclone), trazodone does not act on GABA receptors and does not produce physical dependence or withdrawal seizures. This is the primary advantage driving its popularity among prescribers.
However, abrupt discontinuation after prolonged use can cause a withdrawal-like syndrome including rebound insomnia, anxiety, irritability, and flu-like symptoms. These effects are generally mild compared to benzodiazepine withdrawal and resolve within 3 to 7 days. Tapering the dose gradually over 1 to 2 weeks when discontinuing is recommended to minimize discomfort.
Tolerance to trazodone’s sleep effects can develop over time, though this appears less common than with benzodiazepines. A study in Sleep found that trazodone maintained its sleep-promoting effects over 12 weeks of nightly use without significant dose escalation in most subjects.
Trazodone vs Other Sleep Medications
Compared to zolpidem (Ambien), trazodone produces less risk of complex sleep behaviors (sleepwalking, sleep-eating, sleep-driving), less amnesia, and no controlled substance restrictions. However, zolpidem has a shorter half-life and less next-day sedation for most users.
Compared to melatonin, trazodone is significantly more potent for inducing and maintaining sleep. Melatonin works primarily as a circadian timing signal rather than a sedative, and at standard doses (0.5 to 3 mg) provides modest sleep onset improvement. Trazodone is more appropriate for moderate to severe insomnia where melatonin has proven insufficient.
Compared to doxepin (Silenor), which is the only FDA-approved antidepressant for insomnia, trazodone has a stronger sedative effect but a longer half-life. Doxepin at sleep doses (3 to 6 mg) has fewer side effects but may not be sufficient for people who struggle primarily with sleep onset rather than sleep maintenance.
Long-Term Safety Considerations
Long-term studies of trazodone for insomnia are limited, as most clinical trials evaluate 4 to 12 weeks of use. Available data suggest that trazodone at sleep doses does not cause significant organ toxicity, cognitive decline, or increased mortality risk.
However, the American Academy of Sleep Medicine notes that cognitive behavioral therapy for insomnia (CBT-I) should be the first-line treatment for chronic insomnia, with medications reserved for cases where CBT-I is insufficient, unavailable, or the patient is unable to engage with the therapy. For those who do use trazodone long-term, periodic reassessment of the need for continued medication is appropriate.
Older adults (over 65) should use lower doses (starting at 12.5 to 25 mg) due to increased sensitivity to sedation, higher risk of falls from orthostatic hypotension, and slower drug metabolism. The Beers Criteria lists trazodone as a medication requiring caution in the elderly, primarily due to fall risk.
Frequently Asked Questions
Can you take trazodone every night for sleep?
Many patients use trazodone nightly for months or years under physician supervision. It does not carry the same dependency risk as benzodiazepines. However, periodic evaluation of sleep hygiene practices and consideration of non-pharmacologic approaches is recommended.
What happens if trazodone does not make you sleepy?
Some individuals metabolize trazodone quickly or have receptor variations that reduce sedative response. If 100 mg does not produce adequate sedation, rather than continuing to increase the dose, discuss alternative medications with your provider. Trazodone is not effective for all types of insomnia.
Can you take melatonin with trazodone?
Low-dose melatonin (0.5 to 1 mg) is generally safe to combine with trazodone and may improve sleep onset while trazodone provides sleep maintenance. However, combining multiple sedating substances increases morning drowsiness risk. Consult your prescriber before combining.
Does trazodone affect REM sleep?
Trazodone mildly suppresses REM sleep at higher doses but preserves or enhances slow-wave (deep) sleep at typical sleep doses of 50 to 100 mg. Some users report more vivid dreams, which may reflect enhanced slow-wave to REM transitions rather than overall REM suppression.
